Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2026-03-04 | Forward | 2:1 |
| 2026-03-03 | Forward | 2:1 |
Brainsway Ltd. develops noninvasive neurostimulation treatments using Deep Transcranial Magnetic Stimulation for various mental health and neurological disorders, serving medical professionals worldwide.

A non-invasive medical device utilizing patented H-Coils for deep transcranial magnetic stimulation to treat psychiatric and neurological conditions like depression, OCD, and smoking cessation, with multiple FDA-cleared indications.
| Map | REGION | Q3-2020 | Q4-2020 |
|---|---|---|---|
![]() | U S | $13.3M | — |
![]() | Europe | $1.51M | — |
![]() | Other | $183K | — |
![]() | ISRAEL | -$4K | $154K ▲ |
Overall rating: B+
| PEER | PRICE | |
|---|---|---|
DCTH | $16.48 | COMPARE |
CERS | $2.59 | COMPARE |
NPCE | $14.90 | COMPARE |
TCMD | $21.87 | COMPARE |
SGHT | $8.35 | COMPARE |
MASS | $10.05 | COMPARE |
SENS | $9.63 | COMPARE |
VMD | $9.08 | COMPARE |